Conference Coverage

Consider spironolactone in treatment-resistant hypertension


 

REPORTING FROM ACC 18


Dr. Thompson noted that it’s not possible to look at prescription-filling rates in the PINNACLE registry.

“Unfortunately, we can’t exclude white coat hypertension or nonadherence as reasons why patients in PINNACLE end up on multiple antihypertensive medication classes. We can see that a prescription was written, but we have no way to know if it was actually filled or not,” she observed.

Also, since patients in cardiology clinics typically have multiple cardiovascular comorbidities, it’s quite possible that patients with TRH who are on a beta-blocker, for example, might not have received that drug for blood pressure control.

Dr. Thompson’s study was supported by the ACC’s National Cardiovascular Disease Registry. She reported having no financial conflicts of interest.

Source: Thompson L. ACC 18. Abstract 1324M-09.

Pages

Recommended Reading

ACC Day 3: Finishing strong in Late-Breaking Clinical Trial Sessions
MDedge Cardiology
Phosphodiesterase-5 inhibitors often prescribed inappropriately
MDedge Cardiology
Barbershop intervention cuts blood pressure in black men
MDedge Cardiology
Major message: Most heart failure is preventable
MDedge Cardiology
Balloon pulmonary angioplasty for CTEPH improves heart failure symptoms
MDedge Cardiology
Higher preconception blood pressure linked to pregnancy loss
MDedge Cardiology
Distinguish neurogenic from nonneurogenic orthostatic hypotension
MDedge Cardiology
EAGLES: Smoking cessation therapy did not up cardiovascular risk
MDedge Cardiology
VIDEO: Triple-antihypertensive pill nails early therapy
MDedge Cardiology
MDedge Daily News: Diabetes patients ignore a deadly risk
MDedge Cardiology